Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Tasnim, Humayra
Rannpháirtithe:	khan, Tanisha Tabassum Sayka
Formáid:	Tráchtas
Teanga:	en_US
Foilsithe / Cruthaithe:	Brac University 2022
Ábhair:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Rochtain ar líne:	http://hdl.handle.net/10361/17515

Míreanna comhchosúla

Current practice and approaches of immunotherapy in Cancer treatment
de réir: Khondokar, Faiza
Foilsithe / Cruthaithe: (2022)

A review on targeted therapies for lung cancer
de réir: Ashraf, Anushey
Foilsithe / Cruthaithe: (2023)

Immunotherapy in the treatment of renal cancer
de réir: Shimu, Sumaya
Foilsithe / Cruthaithe: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
de réir: Ratu, Tabassum
Foilsithe / Cruthaithe: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
de réir: Fred, Namanda Rogers
Foilsithe / Cruthaithe: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
de réir: Rahman, Samia
Foilsithe / Cruthaithe: (2022)

CAR-T cell Therapy in B-cell Lymphoma
de réir: Faruk, Asef
Foilsithe / Cruthaithe: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
de réir: Flora, Sanzida Alam
Foilsithe / Cruthaithe: (2024)

Dendritic cell vaccine for the treatment of cancer
de réir: Haque, Tanzila
Foilsithe / Cruthaithe: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
de réir: Abir, Shifaty Nur
Foilsithe / Cruthaithe: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
de réir: Bristy, Israt Zerin
Foilsithe / Cruthaithe: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
de réir: Khan, Rezia Nowrin
Foilsithe / Cruthaithe: (2021)

Stem cell in cancer disease cure vs cause
de réir: Chowdhury, Marisha Mansur
Foilsithe / Cruthaithe: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2024)

Molecules associated with the development of lung cancer
de réir: Rahman, Adree, et al.
Foilsithe / Cruthaithe: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
de réir: Rahman, Sanjida
Foilsithe / Cruthaithe: (2024)

Potential of liposomes for the treatment of lung cancer- a review
de réir: Mim, Shanzida
Foilsithe / Cruthaithe: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
de réir: Rahman, Tasnim
Foilsithe / Cruthaithe: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2023)

A review on recent advances in drugs for lung cancer treatment
de réir: Noor, Fouzia
Foilsithe / Cruthaithe: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
de réir: Jeba, Joynob
Foilsithe / Cruthaithe: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
de réir: Razna, Amrin Islam
Foilsithe / Cruthaithe: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
de réir: Meem, Manila
Foilsithe / Cruthaithe: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
de réir: Islam, Saidul
Foilsithe / Cruthaithe: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
de réir: Pial, Sazia Afrin
Foilsithe / Cruthaithe: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
de réir: Paul, Pulock
Foilsithe / Cruthaithe: (2024)

Stem cells as therapeutic carrier in cancer treatment
de réir: Anika, Mysha Yeasmin
Foilsithe / Cruthaithe: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
de réir: Emon, Kamrul Hasan
Foilsithe / Cruthaithe: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
de réir: Shabnam, Musharrat
Foilsithe / Cruthaithe: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
de réir: Zangmo, Thinley
Foilsithe / Cruthaithe: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
de réir: Hoque, Ismoth Ara
Foilsithe / Cruthaithe: (2024)

A comprehensive review on drug repurposing in cancer treatment
de réir: Sarkar, Onusree
Foilsithe / Cruthaithe: (2024)

Lung cancer detection and classification using machine learning
de réir: Arefin, Mahbubul, et al.
Foilsithe / Cruthaithe: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
de réir: Nandy, Aditi
Foilsithe / Cruthaithe: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
de réir: Alam, Kazi Tasnuva
Foilsithe / Cruthaithe: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
de réir: Pecorino, Lauren
Foilsithe / Cruthaithe: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
de réir: Khan, Muidul Hasan
Foilsithe / Cruthaithe: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
de réir: Kamal, Tasnova
Foilsithe / Cruthaithe: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
de réir: Hasan, Amit
Foilsithe / Cruthaithe: (2024)